Ocata Therapeutics, Inc.
Pharmaceutical company · Marlborough, Massachusetts, United States
Ocata Therapeutics, Inc. is a pharmaceutical company headquartered in Marlborough, Massachusetts, United States. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $1.1 million in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $2.8 million sold in a notice filed in 2009.
Ocata Therapeutics at a glance
What does Ocata Therapeutics do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $1.1 million in total (1999 to 2015).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.8 million sold (2009).
Frequently asked questions about Ocata Therapeutics
Where is Ocata Therapeutics headquartered?
Ocata Therapeutics, Inc. is headquartered in Marlborough, Massachusetts, United States.
What does Ocata Therapeutics do?
Ocata Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences